PHARMA WORLD EXPO 2009 will be 24th exhibitions, and is expected to witness record participation.
The event, supported by CHEMTECH Foundation, will display state-of-the-art technologies, equipment, accessories and services from national and international players in each sector. The concurrent International Conferences will deleberate on issues of topical interest to practising professionals.
catalysing industrial GROWTH
CHEMTECH Foundation, India's leading industry association, pioneered in international exhibitions and conferences and has served the Indian chemical and process industry since 1975. Through the CHEMTECH series of events, the Foundation has catalysed industrial growth by creating a platform for strategic alliances and foreign investments in India. These expositions, world class in stature and scope, have served as a meeting point for foreign and Indian companies, Central and state government officials, research institutions and academia. It has offered a unique platform for idea exchange.
The evolution and the growth of Indian Pharmaceutical and Biotech industries have been both reflected and catalyzed by CHEMTECH. PHARMA + BIOTECH WORLD EXPO 2009 is the 24th in the CHEMTECH series of exhibitions, and is expected to witness record participation. PHARMA + BIOTECH WORLD EXPO 2009, the International Exhibition and Conference encompassing the Pharmaceuticals, Biotechnology & allied sectors, will be held in Mumbai from February 12-16, 2009. The event, sponsored by CHEMTECH Foundation, will display state-of-the-art technologies, equipment, accessories and services from national and international players in each sector. The concurrent international conferences will deliberate on issues of topical interest to practising professionals.
Industry Poised for High Growth
The Rs 25,000 crore (USD 5 billion) Pharma Industry has an average growth rate of 9% over the last 5 years, with exports of USD 1.75 billion. The industry is a net exporter having 8% market share (in volume terms) of the USD 340 billion global market. It is rapidly restructuring to the post-2005 product patent regime.
The industry is now focusing on discovering new molecules by compressing time and reducing the cost of drug discovery. With liberalized economy, the Pharma multinationals are expanding operations in India and Indian companies are increasingly setting up operations and entering into joint ventures abroad. Numerous mergers and acquisitions are taking place to increase core competencies.
Biotechnology, the sunrise industry, is expected to vastly improve the quality of life and the 21st century is now universally termed as the Century of Biotechnology. India has some 800 companies in the traditional biotech sector, but over two dozen companies have now been operating in the third generation modern biotechnology. The country, with abundant generic diversity, has already begun to unfurl the human genome to develop genebased drugs. As both Central and state governments are backing the industry, a sizeable number of biotech parks are coming up in different states. India, therefore, will continue to have an exponential growth in this sector as investments in research and existing units expand and new units create additional capacities. |
